Search clinical trials for: Paclitaxel (Taxol)
Total 4097 results
-
Washington University School of MedicineWithdrawn
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingPeritoneal Carcinomatosis | Clinical Stage IV Gastric Cancer AJCC v8 | Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 | Metastatic Gastric Adenocarcinoma | Metastatic Gastroesophageal Junction Adenocarcinoma | Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma... and other conditionsUnited States
-
Spanish Lung Cancer GroupCompletedNon-Small-Cell Lung Cancer
-
Nanjing Luye Sike Pharmaceutical Co., Ltd.Unknown
-
Daehwa Pharmaceutical Co., Ltd.Active, not recruitingRecurrent or Metastatic Breast CancerChina, Korea, Republic of, Serbia, Bulgaria, Hungary
-
Daehwa Pharmaceutical Co., Ltd.CompletedRecurrent or Metastatic Breast CancerUnited States, Czechia
-
GOG FoundationNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube... and other conditionsUnited States
-
M.D. Anderson Cancer CenterCompletedPenile CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedGastric Cancer | Esophageal CancerUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast CarcinomaUnited States
-
PfizerTerminatedCarcinoma, Non-Small-Cell LungAustralia, United States, Hungary, Germany, Italy, Korea, Republic of, Spain, Sweden, Mexico, South Africa, Taiwan, Belgium, Canada, China, Cyprus, Czech Republic, France, Greece, Hong Kong, India, Israel, Netherlands, Poland, Portugal, Switzerlan... and more
-
GOG FoundationNational Cancer Institute (NCI)Active, not recruitingOvarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian Tube Clear Cell Adenocarcinoma and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast... and other conditionsUnited States
-
PfizerTerminatedCarcinoma, Non-Small-Cell LungUnited States
-
Georgetown UniversityNational Cancer Institute (NCI)TerminatedBreast CancerUnited States
-
Achieve Life SciencesTerminatedBreast NeoplasmUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
RenJi HospitalRecruitingTubular Breast Cancer | Mucinous Breast Cancer | Invasive Duct Carcinoma of BreastChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Gateway for Cancer ResearchActive, not recruitingPrimary Peritoneal Cancer | Fallopian Tube | Epithelial OvarianUnited States
-
INSYS Therapeutics IncCompletedNeoplasmUnited States, Germany, Netherlands
-
University of KansasNovartisWithdrawn
-
OnxeoSpectrum Pharmaceuticals, IncCompletedCarcinoma of Unknown PrimaryUnited States, Germany, France, Denmark
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Male Breast Carcinoma | Adult Solid NeoplasmUnited States
-
University of Michigan Rogel Cancer CenterRecruitingBreast CancerUnited States
-
University of Alabama at BirminghamNovartis PharmaceuticalsCompletedRecurrent Ovarian CancerUnited States
-
CelgeneCompletedNon-Small Cell Lung CarcinomaUnited States, Canada
-
Daehwa Pharmaceutical Co., Ltd.Completed
-
Barbara Parker, MDOncternal Therapeutics, IncCompletedBreast NeoplasmsUnited States
-
NYU Langone HealthNovartisTerminatedOvarian CancerUnited States
-
OHSU Knight Cancer InstituteAstraZeneca; Oregon Health and Science UniversityCompletedStage IV Non-Small Cell Lung Cancer AJCC v7 | Stage IIIB Non-Small Cell Lung Cancer AJCC v7United States
-
National Cancer Institute (NCI)TerminatedTriple-Negative Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Advanced Breast Carcinoma | Metastatic Breast CarcinomaUnited States
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
AbbVieGenentech, Inc.Completed
-
AccentureCompletedRecurrent Platinum-resistant Ovarian CancerAustralia, Russian Federation, United Kingdom
-
Instituto Nacional de Cancer, BrazilUnknownEsophageal Cancer | Induction ChemotherapyBrazil
-
Guangdong Provincial People's HospitalUnknown
-
Jonsson Comprehensive Cancer CenterBristol-Myers SquibbCompleted
-
SanofiCompletedNeoplasms, Germ Cell and EmbryonalFrance
-
Centro Nacional de Investigaciones Oncologicas...M.D. Anderson Cancer Center; Hospital Universitari de Bellvitge; Hospital Universitario...Terminated
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedTransitional Cell CarcinomaUnited States
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Daiichi Sankyo, Inc.CompletedRecurrent Thyroid Cancer | Anaplastic Thyroid CancerUnited States
-
QuantumLeap Healthcare CollaborativeByondis B.V.WithdrawnOvarian Cancer | Metastatic Cancer | Metastatic Breast Cancer | Bladder Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Gastroesophageal Adenocarcinoma | Ovarian Carcinoma | HER2-positive Gastric Cancer | Metastatic Gastrointestinal Carcinoid Tumor | HER2-positive Metastatic Breast... and other conditionsUnited States
-
University of California, San FranciscoNational Cancer Institute (NCI)CompletedBreast Cancer | Gastric Cancer | Esophageal Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Brain and Central Nervous System Tumors | Bladder Cancer | Extragonadal Germ Cell TumorUnited States
-
University of California, IrvineGlaxoSmithKlineCompletedUnresectable Melanoma | Stage IV Melanoma | Stage III MelanomaUnited States
-
University of Michigan Rogel Cancer CenterCompletedBreast CancerUnited States
-
SanofiCompletedCancer | Non-Small Cell Lung Cancer | Endometrial Carcinoma | Ovarian CarcinomaUnited States
-
AHS Cancer Control AlbertaRecruiting
-
Ira WinerRecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Malignant Ovarian Epithelial Tumor | Platinum-Resistant Ovarian Carcinoma | Refractory Ovarian... and other conditionsUnited States